Community
TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Apr 28, 2026
2 min read
34

According to a recent Macquarie review, the Australian stock market faced a challenging month, with the ASX100 and ASX300 indices both falling by 2%. The Small Ordinaries also saw a decrease of 1.8%, reflecting a widespread downturn across the market.
The energy sector stood out as the sole area of growth, posting a 1.9% gain. Key contributors to this positive performance included Woodside Energy, Ampol, and Santos. In stark contrast, the healthcare sector was the worst performer, declining by 6.1%, dragged down by major stocks such as Cochlear, CSL, and ResMed Inc.
Market valuation metrics showed a decrease, with the price-to-earnings ratio for June 2026 falling to 18.3x. Furthermore, the four-week rolling FactSet Australian earnings net revisions were negative, indicating that more earnings forecasts were revised downwards than upwards during the period.
The overall negative sentiment in the Australian market is underscored by broad index declines and negative earnings revisions. The energy sector's resilience provides a single bright spot, while the healthcare sector's significant drop highlights prevailing investor concerns.
Q: Which sector was the only one to grow in Australia last month?
A: The energy sector was the only one to post positive returns, rising by 1.9%.
Q: How did the main Australian stock indices perform?
A: The ASX100 and ASX300 both decreased by 2%, indicating a broad market decline.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles